Description

Rabicip-L Capsule is a medicine composed of Rabeprazole and Levosulpiride. Rabeprazole belongs to the proton pump inhibitor (PPI) class of drugs, while Levosulpiride is a selective dopamine antagonist. This combination is primarily prescribed for the treatment of various gastrointestinal disorders. Rabeprazole helps reduce the production of stomach acid, providing relief from conditions like gastroesophageal reflux disease (GERD), gastritis, and peptic ulcers. Levosulpiride acts as a prokinetic agent, aiding in improving gastrointestinal motility and reducing symptoms such as bloating, nausea, and vomiting. Rabicip-L Capsule effectively manages acid-related disorders by targeting both excessive acid production and gastrointestinal motility. It is commonly used under medical supervision for the management of acid reflux, heartburn, indigestion, and other related conditions. The dosage and duration of treatment may vary depending on the patient’s condition and response to therapy.

Additional information